What is Miromatrix Medical's stock price target for 2024?

0 analysts have issued 1-year price targets for Miromatrix Medical's shares. Their MIRO share price targets range from $3.00 to $3.00. On average, they expect the company's stock price to reach $3.00 in the next twelve months. This suggests that the stock has a possible downside of 11.5%. View analysts price targets for MIRO or view top-rated stocks among Wall Street analysts .

How were Miromatrix Medical's earnings last quarter?

Miromatrix Medical Inc. (NASDAQ:MIRO) released its quarterly earnings data on Monday, November, 15th. The company reported ($0.25) EPS for the quarter, missing the consensus estimate of ($0.13) by $0.12. The firm earned $0.01 million during the quarter. Miromatrix Medical had a negative trailing twelve-month return on equity of 120.49% and a negative net margin of 2,861.17%.

When did Miromatrix Medical IPO?

Miromatrix Medical (MIRO) raised $32 million in an initial public offering (IPO) on Thursday, June 24th 2021. The company issued 4,000,000 shares at $7.00-$9.00 per share. Craig-Hallum Capital Group served as the underwriter for the IPO.

NASDAQ:MIRO

Miromatrix Medical (MIRO) Stock Price, News & Analysis

→ The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad)

Free MIRO Stock Alerts

Notice: This company has been marked as potentially delisted and may not be actively trading.

Compare

Today's Range: $3.39
▼
$3.39
50-Day Range: $3.31
▼
$3.40
52-Week Range: $0.91
▼
$4.35

Volume: N/A
Average Volume: 80,095 shs
Market Capitalization: $92.95 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $3.00

Stock Analysis Analyst Forecasts Earnings Headlines Insider Trades Ownership Short Interest Social Media

Get Miromatrix Medical alerts:

Ad Paradigm Press

AI “wealth window” is closing soon!

Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry.

I put together this personal video [HERE]…

About Miromatrix Medical Stock (NASDAQ:MIRO)

Miromatrix Medical Inc., a life sciences company, develops a novel technology for bioengineering fully transplantable organs. The company's proprietary technology is a platform that uses a two-step method of decellularization and recellularization designed to remove the porcine cells from the organs obtained from pigs and replace them with unmodified human cells. It has collaborations with Baxter, CareDx, The Mayo Clinic, Mount Sinai Hospital, and The Texas Heart Institute. The company was formerly known as TayTech, Inc. Miromatrix Medical Inc. was incorporated in 2009 and is headquartered in Eden Prairie, Minnesota.

Ad Paradigm Press

AI “wealth window” is closing soon!

Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry.

I put together this personal video [HERE]…

MIRO Stock News Headlines

February 22, 2024 | uk.finance.yahoo.com

Q4 2023 United Therapeutics Corp Earnings Call

November 22, 2023 | benzinga.com

Best Stocks to Buy Right Now

April 19, 2024 | Paradigm Press (Ad)

Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS

You might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.

November 15, 2023 | msn.com

Miromatrix Medical GAAP EPS of -$0.24, revenue of $11.17M

November 14, 2023 | finance.yahoo.com

Miromatrix Reports Third Quarter 2023 Results

October 31, 2023 | proactiveinvestors.com

Miromatrix Medical climbs 225% following $140m United Therapeutics bid

October 31, 2023 | msn.com

United Therapeutics agrees to buy Miromatrix Medical

October 31, 2023 | marketwatch.com

Miromatrix Medical Shares Triple After United Therapeutics Offer

April 19, 2024 | Paradigm Press (Ad)

Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS

October 30, 2023 | startribune.com

Eden Prairie biotech company Miromatrix Medical sells for $91M

October 30, 2023 | msn.com

United Therapeutics to buy Miromatrix Medical for $3.25 per share

October 30, 2023 | investorplace.com

Why Is Miromatrix Medical (MIRO) Stock Up 235% Today?

October 11, 2023 | finance.yahoo.com

Miromatrix to Present at the 2023 ISODP Organ Donation Congress

October 5, 2023 | finance.yahoo.com

Miromatrix CEO Jeff Ross to Present at the 2023 Cell & Gene Meeting on the Mesa

September 10, 2023 | finance.yahoo.com

Several Insiders Invested In Miromatrix Medical Flagging Positive News

September 5, 2023 | finance.yahoo.com

Miromatrix Announces Participation in the ARM Tissue Engineering and Therapeutics Workshop

August 21, 2023 | finance.yahoo.com

Miromatrix Medical Inc. (NASDAQ:MIRO) Q2 2023 Earnings Call Transcript

August 15, 2023 | finanznachrichten.de

Miromatrix Medical Inc.: Miromatrix Reports Second Quarter 2023 Results and Provides Corporate Update

August 15, 2023 | msn.com

Miromatrix Medical GAAP EPS of -$0.24

August 15, 2023 | markets.businessinsider.com

Craig-Hallum Keeps Their Buy Rating on Miromatrix Medical (MIRO)

August 15, 2023 | finance.yahoo.com

Q2 2023 Miromatrix Medical Inc Earnings Call

August 14, 2023 | msn.com

Miromatrix Medical GAAP EPS of -$0.24 beats by $0.05, revenue of $8.52M beats by $8.52M

August 14, 2023 | finance.yahoo.com

Miromatrix Reports Second Quarter 2023 Results and Provides Corporate Update

August 11, 2023 | benzinga.com

Preview: Miromatrix Medical's Earnings

August 10, 2023 | msn.com

Lab-grown ‘ghost hearts' work to solve organ transplant shortage by combining a cleaned-out pig heart with a patient’s own stem cells

July 25, 2023 | finance.yahoo.com

Miromatrix to Report Second Quarter 2023 Financial Results

July 13, 2023 | finance.yahoo.com

Miromatrix Poster Voted Best in Congress at the 2023 American Transplant Congress; Jack Lake Wins Lifetime Achievement Award

See More Headlines

Receive MIRO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Miromatrix Medical and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 11/15/2021
Today: 4/18/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Biotechnology
Sub-Industry: N/A
Current Symbol: NASDAQ:MIRO
CUSIP: N/A
CIK: 1527096
Web: www.miromatrix.com
Phone: 952-942-6000
Fax: N/A
Employees: 76
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $3.00
High Stock Price Target: $3.00
Low Stock Price Target: $3.00
Potential Upside/Downside: -11.5%
Consensus Rating
Rating Score (0-4): 0.00
Research Coverage: 0 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($1.14)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-29,960,000.00
Net Margins: -2,861.17%
Pretax Margin: -2,861.17%
Return on Equity: -120.49%
Return on Assets: -90.70%

Debt

Debt-to-Equity Ratio: 0.02
Current Ratio: 3.46
Quick Ratio: 3.46

Sales & Book Value

Annual Sales: $958,029.00
Price / Sales: 97.02
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $1.25 per share
Price / Book: 2.71

Miscellaneous

Outstanding Shares: 27,419,000
Free Float: 25,993,000
Market Cap: $92.95 million
Optionable: Optionable
Beta: 0.01

7 Stocks to Buy And Hold Forever

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Key Executives

Dr. Jeffrey James Ross Ph.D. (Age 47)
CEO & Director
Comp: $797.5k
Mr. James M. Douglas (Age 49)
CFO & Secretary
Comp: $487.5k
Mr. Rodrigo Mesquita P.M.P.
Vice President of Manufacturing & Operations
Mr. Tom Emig
Vice President of People & Culture

Key Competitors

View All Competitors

MIRO Stock Analysis - Frequently Asked Questions

What is Miromatrix Medical's stock price target for 2024?: 0 analysts have issued 1-year price targets for Miromatrix Medical's shares. Their MIRO share price targets range from $3.00 to $3.00. On average, they expect the company's stock price to reach $3.00 in the next twelve months. This suggests that the stock has a possible downside of 11.5%.
View analysts price targets for MIRO or view top-rated stocks among Wall Street analysts.
How were Miromatrix Medical's earnings last quarter?: Miromatrix Medical Inc. (NASDAQ:MIRO) released its quarterly earnings data on Monday, November, 15th. The company reported ($0.25) EPS for the quarter, missing the consensus estimate of ($0.13) by $0.12. The firm earned $0.01 million during the quarter. Miromatrix Medical had a negative trailing twelve-month return on equity of 120.49% and a negative net margin of 2,861.17%.
When did Miromatrix Medical IPO?: Miromatrix Medical (MIRO) raised $32 million in an initial public offering (IPO) on Thursday, June 24th 2021. The company issued 4,000,000 shares at $7.00-$9.00 per share. Craig-Hallum Capital Group served as the underwriter for the IPO.

This page (NASDAQ:MIRO) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Miromatrix Medical (MIRO) Stock Price, News & Analysis

About Miromatrix Medical Stock (NASDAQ:MIRO)

MIRO Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

MIRO Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info